akash.verma@cenmed.com
(732) 447-1115-
MBD0019-0.3UGGeneral description Standardization of sample analysis is currently needed in microbiome genomics research workflow. Lack of standardization can lead to biases and errors in common processes during sample preparation and analysis such as sample -
MBD0023-0.3UGGeneral description Standardization of sample analysis is currently needed in microbiome genomics research workflow. Lack of standardization can lead to biases and errors in common processes during sample preparation and analysis such as sample -
MBD0025-10X1.5MLGeneral description Microbial DNA-free water is filter-sterilized and UV- treated. It undergoes stringent quality control testing to ensure that it is free of any detectable levels of DNA. -
-
PZ0336-25MGBiochem/physiol Actions TMI-1 (WAY-171318) is potent inhibitor of disintegrin metalloenzyme 17 (ADAM17) also known as the tumor necrosis factor-α: (TNF-α:) converting enzyme (TACE), and matrix metalloprotease (MMP). TMI-1 potently -
PZ0336-5MGBiochem/physiol Actions TMI-1 (WAY-171318) is potent inhibitor of disintegrin metalloenzyme 17 (ADAM17) also known as the tumor necrosis factor-α: (TNF-α:) converting enzyme (TACE), and matrix metalloprotease (MMP). TMI-1 potently -
SML0349-25MGApplication Neferine has been used to study its effect in autophagy signalling. Biochem/physiol Actions Neferine is a bis-benzylisoquinoline alkaloid isolated from the green seed embryos Nelumbo Nucifera Gaertn (Lotus) that displays multiple -
SML0349-5MGApplication Neferine has been used to study its effect in autophagy signalling. Biochem/physiol Actions Neferine is a bis-benzylisoquinoline alkaloid isolated from the green seed embryos Nelumbo Nucifera Gaertn (Lotus) that displays multiple -
SML0371-25MGBiochem/physiol Actions MLR-1023 has a therapeutic potential to treat type 2 diabetes. MLR-1023 is a potent, orally active, allosteric activator of the non-receptor Src-related Lyn kinase that produces lasting glucose lowering, reduces HbA1c -
SML0371-5MGBiochem/physiol Actions MLR-1023 has a therapeutic potential to treat type 2 diabetes. MLR-1023 is a potent, orally active, allosteric activator of the non-receptor Src-related Lyn kinase that produces lasting glucose lowering, reduces HbA1c -
CRISPRIS01-1KTGeneral description CRISPRi is a potent tool for modulating gene expression. This technology uses dCas9 to act as a synthetic transcription factors by recruiting endogenous transcription repressor complexes to gene promoters and enhancers, -
A15049-36Formula: C4H10N2 Formula weight: 86.14 Purity: 99% CAS Number: 110-85-0 UN Number: UN2579 Hazard Class: 8 Packing Group: III Harmonized Tariff Code: 2933.
